share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  May 15 23:45
Summary by Futu AI
Vertex Pharmaceuticals Inc. officer David Altshuler is set to sell 54 shares of common stock on 05/15/2024, with an aggregate market value of $23,270.22. The shares were acquired through an Employee Stock Purchase Plan (ESPP) on 05/14/2024, a day prior to the planned sale, and were paid for in cash. This transaction follows a three-month period where a total of 11,243 shares were sold by company insiders, generating gross proceeds of $4,754,697.42.
Vertex Pharmaceuticals Inc. officer David Altshuler is set to sell 54 shares of common stock on 05/15/2024, with an aggregate market value of $23,270.22. The shares were acquired through an Employee Stock Purchase Plan (ESPP) on 05/14/2024, a day prior to the planned sale, and were paid for in cash. This transaction follows a three-month period where a total of 11,243 shares were sold by company insiders, generating gross proceeds of $4,754,697.42.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.